Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32487513
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Transfus+Apher+Sci
2020 ; 59
(5
): 102821
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with
disseminated tuberculosis
#MMPMID32487513
Ç?nar OE
; Say?nalp B
; Alada? Karakulak E
; Av?ar Karata? A
; Velet M
; ?nkaya AÇ
; Ersoy Ortaç NE
; Öcal S
; Aksu S
; Haznedaro?lu ?C
; Say?nalp N
; Özcebe O?
Transfus Apher Sci
2020[Oct]; 59
(5
): 102821
PMID32487513
show ga
During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which
evidence-based medical paradigms cannot be easily applied; difficult clinical
decisions shall be required particularly in the 'difficult-to-treat' cases of
high risk group with associated comorbidities. Convalescent immune plasma therapy
is a promising option as a sort of 'rescue' treatment in COVID-19 immune
syndrome, where miraculous antiviral drugs are not available yet. In this report,
we aim to convey our experience of multi-task treatment approach with
convalescent immune plasma and anti-cytokine drug combination in a COVID-19
patient with extremely challenging comorbidities including active myeloid
malignancy, disseminated tuberculosis and kidney failure.